Redeye provides an initial take on Kontigo Care’s Q3 2025 results. Sales, MRR, and EBIT were broadly in line with expectations, while a lower cost base and reduced capitalisations offset each other at the EBIT level. The key highlight is that both sales and MRR increased q/q, with additional upside expected from secured contracts. Only minor estimate revisions are expected.
LÄS MER
